Jörg Rosenberg

This inventor holds 12 USPTO granted patents and 8 published patent applications and 16 EPO patents. Top assignees: Abbvie Deutschland Gmbh and Co Kg, Abbott Gmbh & Co Kg, Basf Aktiengesellschaft. Active years: 2006-2020.

USPTO Granted Patents = 12 (Patent Applications = 8)

% Patents Active = 33.3

EPO Patents = 16 (Patent Applications = 12)

Average Co-Inventor Count = 4.9

ph-index = 4

Forward Citations = 42(Granted Patents)

Company Filing History:

7 out of 167

Abbvie Deutschland Gmbh and Co Kg

Basf Aktiengesellschaft

Years Active: 2006-2020

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10653625 - Production of dosage forms comprising a solid dispersion of a microcrystalline agent (2020-05-19),

2. 9616130 - Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same (2017-04-11),

3. 9414992 - Process for producing a solid dispersion of an active ingredient (2016-08-16),

4. 9205027 - Process for producing a solid dispersion of an active ingredient (2015-12-08),

5. 9078921 - Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same (2015-07-14),

6. 9028876 - Rate-controlled particles (2015-05-12),

7. 8673344 - Solid dosage form with a film containing an active substance, as well as its method of production (2014-03-18),

8. 8470347 - Self-emulsifying active substance formulation and use of this formulation (2013-06-25),

9. 8337733 - Preparation of compositions with essentially noncrystalline embedded macrolide antibiotics (2012-12-25),

10. 7846477 - Method for producing solid galenic formulations using a crosslinked non-thermoplastic carrier (2010-12-07),

11. 7393840 - Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base (2008-07-01),

12. 7014810 - Method of producing solid shape forms containing an active ingredient (2006-03-21),

Title: Jörg Rosenberg: Innovator in Pharmaceutical Dosage Forms

Introduction

Jörg Rosenberg is a notable inventor based in Ellerstadt, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. With a total of 12 patents to his name, Rosenberg's work has had a considerable impact on enhancing drug delivery systems.

Latest Patents

Rosenberg's latest patents include a method for the production of dosage forms that comprise a solid dispersion of a microcrystalline active substance. This method involves melting a thermoplastic polymer with a glass transition temperature of at least 40°C and dissolving the active substance homogeneously in the melt. The crystallization of the active substance is initiated in the mass obtained, and the mass is subsequently cooled. Additionally, he has developed pharmaceutically acceptable solubilizing compositions that enhance the bioavailability of active ingredients following oral intake. These compositions comprise tocopheryl compounds and alkylene glycol fatty acid monoesters, which are useful in the manufacture of pharmaceutical dosage forms.

Career Highlights

Throughout his career, Jörg Rosenberg has worked with prominent companies in the pharmaceutical industry, including AbbVie Deutschland GmbH & Co. KG and Abbott GmbH & Co. KG. His expertise in pharmaceutical formulations has been instrumental in advancing the development of effective drug delivery systems.

Collaborations

Rosenberg has collaborated with several professionals in his field, including Jörg Breitenbach and Christoph Schmidt. These collaborations have contributed to the successful development of innovative pharmaceutical solutions.

Conclusion

Jörg Rosenberg's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence the development of effective dosage forms that enhance drug delivery and bioavailability.